IMDX logo

IMDX
Insight Molecular Diagnostics Inc.

3,678
Mkt Cap
$134.46M
Volume
417.00
52W High
$8.51
52W Low
$2.33
PE Ratio
-3.23
IMDX Fundamentals
Price
$5.23
Prev Close
$4.18
Open
$4.18
50D MA
$4.26
Beta
0.59
Avg. Volume
385,731.78
EPS (Annual)
-$1.65
P/B
-4.77
Rev/Employee
$69,913.79
$219.76
Loading...
Loading...
News
all
press releases
Monday Sector Leaders: Biotechnology, Oil & Gas Refining & Marketing Stocks
In trading on Monday, biotechnology shares were relative leaders, up on the day by about 2.1%. Leading the group were shares of Insight Molecular Diagnostics, up about 22.8% and shares of Replimune...
Nasdaq News: Markets·16h ago
News Placeholder
More News
News Placeholder
Insider Buying: Oncocyte (NASDAQ:IMDX) Major Shareholder Purchases 250,923 Shares of Stock
Oncocyte Corp (NASDAQ:IMDX - Get Free Report) major shareholder Broadwood Partners, L.P. bought 250,923 shares of the firm's stock in a transaction dated Monday, April 27th. The stock was acquired at...
MarketBeat·7d ago
News Placeholder
Broadwood Partners, L.P. Buys 250,923 Shares of Oncocyte (NASDAQ:IMDX) Stock
Oncocyte Corp (NASDAQ:IMDX - Get Free Report) major shareholder Broadwood Partners, L.P. acquired 250,923 shares of the firm's stock in a transaction that occurred on Monday, April 27th. The stock...
MarketBeat·7d ago
News Placeholder
Oncocyte (NASDAQ:IMDX) Major Shareholder Broadwood Partners, L.P. Acquires 280,381 Shares
Oncocyte Corp (NASDAQ:IMDX - Get Free Report) major shareholder Broadwood Partners, L.P. acquired 280,381 shares of the company's stock in a transaction dated Thursday, April 23rd. The shares were...
MarketBeat·7d ago
News Placeholder
Oncocyte (NASDAQ:IMDX) Major Shareholder Broadwood Partners, L.P. Purchases 38,880 Shares
Oncocyte Corp (NASDAQ:IMDX - Get Free Report) major shareholder Broadwood Partners, L.P. bought 38,880 shares of the stock in a transaction dated Friday, April 24th. The stock was purchased at an...
MarketBeat·7d ago
News Placeholder
Broadwood Partners, L.P. Purchases 40,114 Shares of Oncocyte (NASDAQ:IMDX) Stock
Oncocyte Corp (NASDAQ:IMDX - Get Free Report) major shareholder Broadwood Partners, L.P. acquired 40,114 shares of Oncocyte stock in a transaction that occurred on Friday, April 17th. The shares were...
MarketBeat·14d ago
News Placeholder
Oncocyte (NASDAQ:IMDX) Major Shareholder Purchases $352,096.65 in Stock
Oncocyte Corp (NASDAQ:IMDX - Get Free Report) major shareholder Broadwood Partners, L.P. purchased 102,057 shares of Oncocyte stock in a transaction on Thursday, April 16th. The stock was acquired at...
MarketBeat·14d ago
News Placeholder
Oncocyte (NASDAQ:IMDX) Major Shareholder Acquires $157,877.20 in Stock
Oncocyte Corp (NASDAQ:IMDX - Get Free Report) major shareholder Broadwood Partners, L.P. purchased 40,690 shares of Oncocyte stock in a transaction dated Monday, April 20th. The stock was bought at...
MarketBeat·14d ago
News Placeholder
Oncocyte (NASDAQ:IMDX) Major Shareholder Acquires $143,206.98 in Stock
Oncocyte Corp (NASDAQ:IMDX - Get Free Report) major shareholder Broadwood Partners, L.P. acquired 40,114 shares of the stock in a transaction that occurred on Friday, April 17th. The shares were...
MarketBeat·14d ago
News Placeholder
Tuesday Sector Leaders: Biotechnology, Medical Instruments & Supplies
In trading on Tuesday, biotechnology shares were relative leaders, up on the day by about 3.4%. Leading the group were shares of Travere Therapeutics, up about 34.1% and shares of Insight Molecular Diagnostics up about 33% on the day. Also showing relative strength are medical...
Nasdaq News: Markets·21d ago
<
1
2
...
>

Latest IMDX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.